Maxim analyst Jason McCarthy is out today with a research note on shares of Kite Pharma Inc (NASDAQ:KITE), after holding a first China focused Healthcare …
Maxim analyst Jason McCarthy is out today with a new research note on shares of Keryx Biopharmaceuticals (NASDAQ:KERX), after the drug maker reported fourth quarter …
Maxim analyst Jason McCarthy reiterated a Hold rating on shares of Inovio Pharmaceuticals Inc (NASDAQ:INO), after the vaccine maker presented positive clinical data for DNA-based …
OncoSec Medical Inc (NASDAQ:ONCS) shares are rising almost 8% ahead of the biotech firm’s immune data presentation tomorrow at the American Association for …
Maxim analyst Jason McCarthy provides insight on Juno Therapeutics Inc (NASDAQ:JUNO) amid the hold placed on the firm’s JCAR015 ROCKET study, which arose …
Galena Biopharma Inc (NASDAQ:GALE) has announced it will have two post presentations at next week’s San Antonio Breast Cancer Symposium: “VADIS Trial: Phase …
Anavex Life Sciences Corp. (NASDAQ:AVXL) shares are on a 10% rise after biotech firm Lilly’s drug Solanezumab (“Sola”) just failed its third Phase …
In a research report published Wednesday, Maxim analyst Jason McCarthy reiterated a Buy rating on shares of Juno Therapeutics Inc (NASDAQ:JUNO), while reducing …
Yesterday, Galena Biopharma Inc (NASDAQ:GALE) released third-quarter earnings and offered a clinical progress update on its pipeline. In reaction, Maxim analyst Jason McCarthy …
As the biotech community debates Opexa Therapeutics Inc’s (NASDAQ:OPXA) clinical trial setback in Secondary Progressive Multiple Sclerosis (SPMS), Maxim analyst Jason McCarthy added further fuel to …
